3rd Quarter - Report

EMERGENT BIOSOLUTIONS INC. for EMERGENT BIOSOLUTIONS INC

Period 3rd Quarter 2024 Filed Oct 16, 2024 Signed by CHRISTOPHER FRECH

Official filing
Firm
EMERGENT BIOSOLUTIONS INC.
Client
EMERGENT BIOSOLUTIONS INC
Income
—
Expenses
$500,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Disaster Planning/Emergencies DIS

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25. Naloxone access and awareness legislation. State opioid response (SOR) Grant funding for FY25. Substance Abuse and Mental Health Block Grant (SABG) funding and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R.5420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240.

LobbyistCovered position, as disclosed
MATTHEW FITTING —
CHRIS FRECH —
KATHERINE GETTY —

Contacted: White House Office; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3065 (118th), H.R. 6161 (118th), S. 2946 (118th), H.R. 6243 (118th), H.R. 4240 (118th), H.R. 4582 (118th), H.R. 5420 (118th), S. 2948 (118th), H.R. 5506 (118th)

Budget/Appropriations BUD

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25. Naloxone access and awareness legislation. State opioid response (SOR) Grant funding for FY25. Substance Abuse and Mental Health Block Grant (SABG) funding and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R.5420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240.

LobbyistCovered position, as disclosed
MATTHEW FITTING —
CHRIS FRECH —
KATHERINE GETTY —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; White House Office; SENATE

Bills named: H.R. 5420 (118th), H.R. 6243 (118th), H.R. 5506 (118th), S. 2946 (118th), H.R. 3065 (118th), S. 2948 (118th), H.R. 4240 (118th), H.R. 4582 (118th), H.R. 6161 (118th)

Health Issues HCR

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25. Naloxone access and awareness legislation. State opioid response (SOR) Grant funding for FY25. Substance Abuse and Mental Health Block Grant (SABG) funding and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R.5420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240.

LobbyistCovered position, as disclosed
MATTHEW FITTING —
CHRIS FRECH —
KATHERINE GETTY —

Contacted: Office of Natl Drug Control Policy (NDCP); HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Bills named: H.R. 6243 (118th), S. 2946 (118th), H.R. 4240 (118th), H.R. 5420 (118th), H.R. 4582 (118th), H.R. 6161 (118th), H.R. 3065 (118th), H.R. 5506 (118th), S. 2948 (118th)

Homeland Security HOM

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25. Naloxone access and awareness legislation. State opioid response (SOR) Grant funding for FY25. Substance Abuse and Mental Health Block Grant (SABG) funding and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R.5420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240.

LobbyistCovered position, as disclosed
MATTHEW FITTING —
CHRIS FRECH —
KATHERINE GETTY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); White House Office

Bills named: H.R. 4240 (118th), H.R. 5420 (118th), S. 2948 (118th), H.R. 6161 (118th), S. 2946 (118th), H.R. 3065 (118th), H.R. 5506 (118th), H.R. 6243 (118th), H.R. 4582 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.